Clarity Pharmaceuticals (ASX:CU6) Tax Rate %: -0.64% (As of Dec. 2025)


ASX:CU6 Clarity Pharmaceuticals Ltd ASX:CU6
39 GF Score
Price A$2.41
! 2 Warning Signs
View Full Analysis

What is Clarity Pharmaceuticals Tax Rate %?

Clarity Pharmaceuticals ASX:CU6 +1.69% 39 Tax Rate % is -0.64% as of Dec. 2025. GuruFocus rates ASX:CU6 with a GF Score™ of 39/100. The stock has 2 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Clarity Pharmaceuticals's Tax Expense for the six months ended in Dec. 2025 was A$0.35 Mil. Clarity Pharmaceuticals's Pre-Tax Income for the six months ended in Dec. 2025 was A$-55.18 Mil. Therefore, Clarity Pharmaceuticals's Tax Rate % for the quarter that ended in Dec. 2025 was -0.64%.

Clarity Pharmaceuticals Tax Rate % Related Terms

Clarity Pharmaceuticals Tax Rate % Historical Data

* Premium members only.

The historical data trend for Clarity Pharmaceuticals's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clarity Pharmaceuticals Tax Rate % Chart

Clarity Pharmaceuticals Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Tax Rate %
-0.08 -0.42 -0.70 -0.65

Clarity Pharmaceuticals Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.61 -0.76 -0.20 -0.92 -0.64
ASX:CU6
39GF Score
Clarity Pharmaceuticals Ltd ASX:CU6
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clarity Pharmaceuticals Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Clarity Pharmaceuticals's Tax Rate % for the fiscal year that ended in Jun. 2025 is calculated as

Tax Rate %=Tax Expense (A: Jun. 2025 )/Pre-Tax Income (A: Jun. 2025 )
=0.417/-63.879
=-0.65 %

Clarity Pharmaceuticals's Tax Rate % for the quarter that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (Q: Dec. 2025 )/Pre-Tax Income (Q: Dec. 2025 )
=0.352/-55.181
=-0.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of -0.64% mean?
Clarity Pharmaceuticals (ASX:CU6) has a Tax Rate % of -0.64% as of Dec. 2025.
Is Clarity Pharmaceuticals' Tax Rate % too high?
Clarity Pharmaceuticals' current Tax Rate % is -0.64%. Overall, Clarity Pharmaceuticals has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Clarity Pharmaceuticals' Tax Rate % compare to VRTX and REGN?
Clarity Pharmaceuticals' Tax Rate % of -0.64% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Clarity Pharmaceuticals's current Tax Rate % is -0.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clarity Pharmaceuticals stock overvalued right now?
Clarity Pharmaceuticals (ASX:CU6) has a current Tax Rate % of -0.64%. The current Tax Rate % is -0.64%. Clarity Pharmaceuticals' overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Clarity Pharmaceuticals (ASX:CU6), the current Tax Rate % is -0.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clarity Pharmaceuticals Business Description

Other Exchanges CLRPF:USA1F4:Germany
Address 2-4 Cornwallis Street, Suite 212a, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, using its SAR Technology platform. Clarity's Targeted Copper Theranostic (TCT) platform of products utilize pairing of copper isotopes, specifically copper-64 (Cu-64 or 64Cu) for imaging and copper-67 Cu-67 or 67Cu) for therapy, which delivers accuracy and precision in the treatment of a range of cancers. The company's clinical development pipeline includes SAR-bisPSMA, SAR-Bombesin, and Sartate, in their different stages of development for the diagnosis and/or treatment of various cancers. Clarity operates in a single segment, which is the development of radiopharmaceuticals. Geographically, it operates in Australia and the United States.
39GF Score

Get the complete analysis for ASX:CU6

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.41
Price